Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 18.

Joosse, M E; Aardoom, M A; Kemos, P; et al; Braegger, C P (2018). Malignancy and mortality in paediatric-onset inflammatory bowel disease: a 3-year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN. Alimentary Pharmacology & Therapeutics, 48(5):523-537.

Ruemmele, F M; Veres, G; Kolho, K L; Griffiths, A; Levine, A; Escher, J C; Amil Dias, J; Barabino, A; Braegger, C P; Bronsky, J; Buderus, S; Martín-de-Carpi, J; De Ridder, L; Fagerberg, U L; Hugot, J P; Kierkus, J; Kolacek, S; Koletzko, S; Lionetti, P; Miele, E; Navas López, V M; Paerregaard, A; Russell, R K; Serban, D E; Shaoul, R; Van Rheenen, P; Veereman, G; Weiss, B; Wilson, D; Dignass, A; Eliakim, A; Winter, H; Turner, D (2014). Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease. Journal of Crohn's & colitis, 8(10):1179-1207.

Braegger, C P (2013). Erkrankungen des Dickdarms. In: Speer, C; Gahr, M. Pädiatrie. Heidelberg: Springer, 587-591.

Friedt, M; Braegger, C P (2013). Morbus Crohn. In: Rodeck, B; Zimmer, K P. Pädiatrische Gastroenterologie. Heidelberg: Springer, 333-361.

Rogler, G; Braegger, C P (2012). Therapie chronisch entzündlicher Darmerkrankungen bei Kindern und Jugendlichen. In: Rogler, G. Aktuelle Therapieoptionen bei chronisch-entzündlichen Darmerkrankungen. Zürich: Uni-Med, 114-119.

Vavricka, S R; Spigaglia, S M; Rogler, G; Pittet, V; Michetti, P; Felley, C; Mottet, C; Braegger, C P; Rogler, D; Straumann, A; Bauerfeind, P; Fried, M; Schoepfer, A M (2011). Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease. Inflammatory Bowel Diseases, 18(3):496-505.

Buehr, P; Braegger, C P (2011). A 12-year-old boy with poor appetite. Clinical Gastroenterology and Hepatology, 9(11):A22.

van Stuijvenberg, M; Eisses, A M; Grüber, C; Mosca, F; Arslanoglu, S; Chirico, G; Braegger, C P; Riedler, J; Boehm, G; Sauer, P J J (2011). Do prebiotics reduce the number of fever episodes in healthy children in their first year of life: a randomised controlled trial. British Journal of Nutrition, 106(11):1740-1748.

Braegger, C P; Ballabeni, P; Rogler, D; Vavricka, S R; Friedt, M; Pittet, V (2011). Epidemiology of inflammatory bowel disease: Is there a shift towards onset at a younger age? Journal of Pediatric Gastroenterology and Nutrition, 53(2):141-144.

MIPS 1 Working Group; Piemontese, P; Gianni, M L; Braegger, C P; Chirico, G; Grüber, C; Riedler, J; Arslanoglu, S; van Stuijvenberg, M; Boehm, G; Jelinek, J; Roggero, P (2011). Tolerance and safety evaluation in a large cohort of healthy infants fed an innovative prebiotic formula: a randomized controlled trial. PLoS ONE, 6(11):e28010.

Pittet, V; Juillerat, P; Michetti, P; Vader, J P; Burnand, B; Rogler, G; Beglinger, C; Seibold, F; Mottet, C; Felley, C; Gonvers, J J; Froehlich, F; et al; Braegger, C P (2010). Appropriateness of therapy for fistulizing Crohn's disease: findings from a national inflammatory bowel disease cohort. Alimentary Pharmacology & Therapeutics, 32(8):1007-1016.

Juillerat, P; Pittet, V; Vader, J P; Burnand, B; Gonvers, J J; de Saussure, P; Mottet, C; Seibold, F; Rogler, G; Sagmeister, M; Felley, C; Michetti, P; Froehlich, F; et al; Braegger, C P (2010). Infliximab for Crohn's disease in the Swiss IBD Cohort Study: clinical management and appropriateness. European Journal of Gastroenterology & Hepatology, 22(11):1352-1357.

Braegger, C P; Rogler, G (2010). Klinische und epidemiologische Aspekte der Zöliakie. Schweizer Zeitschrift für Ernährungsmedizin (SZE), 3:7-10.

Braegger, C P (2010). Probiotics and the prevention of necrotizing enterocolitis. Annals of Nutrition & Metabolism, 57(Supp 1):14-15.

Grüber, C; van Stuijvenberg, M; Mosca, F; Moro, G; Chirico, G; Braegger, C P; Riedler, J; Boehm, G; Wahn, U (2010). Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants. Journal of Allergy and Clinical Immunology, 126(4):791-797.

Zihler, A; Gagnon, M; Chassard, C; Hegland, A; Stevens, M J; Braegger, C P; Lacroix, C (2010). Unexpected consequences of administering bacteriocinogenic probiotic strains for Salmonella populations, revealed by an in vitro colonic model of the child gut. Microbiology, 156(Pt 11):3342-3353.

Braegger, C P (2008). Laktoseintoleranz. Schweizer Zeitschrift für Ernährungsmedizin (SZE), (2):9-11.

Friedt, M; Braegger, C P (2008). Morbus Crohn. In: Rodeck, B; Zimmer, K P. Pädiatrische Gastroenterologie, Hepatologie und Ernährung. Heidelberg: Springer, 275-284.

This list was generated on Wed May 22 03:25:50 2019 CEST.